{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:08:06Z","timestamp":1792519686114,"version":"4.5.0"},"reference-count":75,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2024,2,20]]},"abstract":"<jats:sec id=\"ab-jrv240001-1\"><jats:title>Importance<\/jats:title><jats:p>Paroxysmal supraventricular tachycardia (PSVT), defined as tachyarrhythmias that originate from or conduct through the atria or atrioventricular node with abrupt onset, affects 168 to 332 per 100\u202f000 individuals. Untreated PSVT is associated with adverse outcomes including high symptom burden and tachycardia-mediated cardiomyopathy.<\/jats:p><\/jats:sec><jats:sec id=\"ab-jrv240001-2\"><jats:title>Observations<\/jats:title><jats:p>Approximately 50% of patients with PSVT are aged 45 to 64 years and 67.5% are female. Most common symptoms include palpitations (86%), chest discomfort (47%), and dyspnea (38%). Patients may rarely develop tachycardia-mediated cardiomyopathy (1%) due to PSVT. Diagnosis is made on electrocardiogram during an arrhythmic event or using ambulatory monitoring. First-line acute therapy for hemodynamically stable patients includes vagal maneuvers such as the modified Valsalva maneuver (43% effective) and intravenous adenosine (91% effective). Emergent cardioversion is recommended for patients who are hemodynamically unstable. Catheter ablation is safe, highly effective, and recommended as first-line therapy to prevent recurrence of PSVT. Meta-analysis of observational studies shows single catheter ablation procedure success rates of 94.3% to 98.5%. Evidence is limited for the effectiveness of long-term pharmacotherapy to prevent PSVT. Nonetheless, guidelines recommend therapies including calcium channel blockers, \u03b2-blockers, and antiarrhythmic agents as management options.<\/jats:p><\/jats:sec><jats:sec id=\"ab-jrv240001-3\"><jats:title>Conclusion and Relevance<\/jats:title><jats:p>Paroxysmal SVT affects both adult and pediatric populations and is generally a benign condition. Catheter ablation is the most effective therapy to prevent recurrent PSVT. Pharmacotherapy is an important component of acute and long-term management of PSVT.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jama.2024.0076","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T16:00:54Z","timestamp":1708444854000},"page":"601","source":"Crossref","is-referenced-by-count":41,"title":["Diagnosis and Management of Paroxysmal Supraventricular Tachycardia"],"prefix":"10.1001","volume":"331","author":[{"given":"Gary","family":"Peng","sequence":"first","affiliation":[{"name":"Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul C.","family":"Zei","sequence":"additional","affiliation":[{"name":"Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"14","key":"jrv240001r1","doi-asserted-by":"publisher","first-page":"e471","DOI":"10.1161\/CIR.0000000000000310","article-title":"2015 ACC\/AHA\/HRS guideline for the management of adult patients with supraventricular tachycardia: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.","volume":"133","author":"Page","year":"2016","journal-title":"Circulation"},{"issue":"5","key":"jrv240001r2","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1093\/eurheartj\/ehz467","article-title":"2019 ESC guidelines for the management of patients with supraventricular tachycardia: the Task Force for the Management of Patients With Supraventricular Tachycardia of the European Society of Cardiology (ESC).","volume":"41","author":"Brugada","year":"2020","journal-title":"Eur Heart J"},{"issue":"8","key":"jrv240001r3","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1111\/jce.v32.8","article-title":"Prevalence and incidence of patients with paroxysmal supraventricular tachycardia in the United States.","volume":"32","author":"Rehorn","year":"2021","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"14","key":"jrv240001r4","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.008759","article-title":"Contemporary burden and correlates of symptomatic paroxysmal supraventricular tachycardia.","volume":"7","author":"Go","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"jrv240001r5","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1001\/archpediatrics.2008.547","article-title":"Supraventricular tachycardia.","volume":"163","author":"Salerno","year":"2009","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"10","key":"jrv240001r6","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1016\/j.hrthm.2016.06.006","article-title":"Postnatal cumulative incidence of supraventricular tachycardia in a general pediatric population: a national birth cohort database study.","volume":"13","author":"Wu","year":"2016","journal-title":"Heart Rhythm"},{"issue":"1","key":"jrv240001r7","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/S0735-1097(97)00422-1","article-title":"Paroxysmal supraventricular tachycardia in the general population.","volume":"31","author":"Orejarena","year":"1998","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"jrv240001r8","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1093\/eurheartj\/ehy709","article-title":"A decade of catheter ablation of cardiac arrhythmias in Sweden: ablation practices and outcomes.","volume":"40","author":"Holmqvist","year":"2019","journal-title":"Eur Heart J"},{"issue":"4","key":"jrv240001r9","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.hrthm.2004.05.007","article-title":"Influence of age and gender on the mechanism of supraventricular tachycardia.","volume":"1","author":"Porter","year":"2004","journal-title":"Heart Rhythm"},{"issue":"1","key":"jrv240001r10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jpeds.2007.05.044","article-title":"Cardiac conduction disturbance detected in a pediatric population.","volume":"152","author":"Chiu","year":"2008","journal-title":"J Pediatr"},{"issue":"10","key":"jrv240001r11","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1161\/CIRCULATIONAHA.114.011154","article-title":"Wolff-Parkinson-White syndrome in the era of catheter ablation: insights from a registry study of 2169 patients.","volume":"130","author":"Pappone","year":"2014","journal-title":"Circulation"},{"issue":"4","key":"jrv240001r12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/XCE.0000000000000208","article-title":"Clinical presentation of paroxysmal supraventricular tachycardia: evaluation of usual and unusual symptoms.","volume":"9","author":"Yetkin","year":"2020","journal-title":"Cardiovasc Endocrinol Metab"},{"key":"jrv240001r13","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.hrthm.2020.02.018","article-title":"Common wearable devices demonstrate variable accuracy in measuring heart rate during supraventricular tachycardia.","volume":"17","author":"Sequeira","year":"2020","journal-title":"Heart Rhythm"},{"issue":"2","key":"jrv240001r14","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1093\/ehjdh\/ztab025","article-title":"Artificial intelligence to diagnose paroxysmal supraventricular tachycardia using electrocardiography during normal sinus rhythm.","volume":"2","author":"Jo","year":"2021","journal-title":"Eur Heart J Digit Health"},{"issue":"10005","key":"jrv240001r15","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1016\/S0140-6736(15)61485-4","article-title":"Postural modification to the standard Valsalva manoeuvre for emergency treatment of supraventricular tachycardias (REVERT): a randomised controlled trial.","volume":"386","author":"Appelboam","year":"2015","journal-title":"Lancet"},{"issue":"11","key":"jrv240001r16","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1016\/j.ajem.2017.05.034","article-title":"Comparing the success rates of standard and modified Valsalva maneuvers to terminate PSVT: a randomized controlled trial.","volume":"35","author":"\u00c7orbacioglu","year":"2017","journal-title":"Am J Emerg Med"},{"issue":"1","key":"jrv240001r17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/S0196-0644(98)70277-X","article-title":"Comparison of treatment of supraventricular tachycardia by Valsalva maneuver and carotid sinus massage.","volume":"31","author":"Lim","year":"1998","journal-title":"Ann Emerg Med"},{"issue":"6","key":"jrv240001r18","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.jcin.2014.02.009","article-title":"Adenosine: physiology, pharmacology, and clinical applications.","volume":"7","author":"Layland","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"issue":"4","key":"jrv240001r19","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s40256-023-00581-w","article-title":"The single-syringe versus the double-syringe techniques of adenosine administration for supraventricular tachycardia: a systematic review and meta-analysis.","volume":"23","author":"Miyawaki","year":"2023","journal-title":"Am J Cardiovasc Drugs"},{"issue":"12","key":"jrv240001r20","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.118.006953","article-title":"Supraventricular tachycardia: mechanistic insights deduced from adenosine.","volume":"11","author":"Lerman","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"10","key":"jrv240001r21","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005154.pub4","article-title":"Adenosine versus intravenous calcium channel antagonists for supraventricular tachycardia.","volume":"10","author":"Alabed","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"25","key":"jrv240001r22","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1161\/CIRCULATIONAHA.117.028087","article-title":"Prospective study of adenosine on atrioventricular nodal conduction in pediatric and young adult patients after heart transplantation.","volume":"135","author":"Flyer","year":"2017","journal-title":"Circulation"},{"issue":"10396","key":"jrv240001r23","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/S0140-6736(23)00776-6","article-title":"Self-administered intranasal etripamil using a symptom-prompted, repeat-dose regimen for atrioventricular-nodal-dependent supraventricular tachycardia (RAPID): a multicentre, randomised trial.","volume":"402","author":"Stambler","year":"2023","journal-title":"Lancet"},{"issue":"5","key":"jrv240001r24","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.jacc.2018.04.082","article-title":"Etripamil nasal spray for rapid conversion of supraventricular tachycardia to sinus rhythm.","volume":"72","author":"Stambler","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"jrv240001r25","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.122.010915","article-title":"First randomized, multicenter, placebo-controlled study of self-administered intranasal etripamil for acute conversion of spontaneous paroxysmal supraventricular tachycardia (NODE-301).","volume":"15","author":"Stambler","year":"2022","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"10","key":"jrv240001r26","first-page":"969","article-title":"Comparison of efficacy of intravenous diltiazem and esmolol in terminating supraventricular tachycardia.","volume":"47","author":"Gupta","year":"1999","journal-title":"J Assoc Physicians India"},{"issue":"2","key":"jrv240001r27","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/S0735-1097(00)01128-1","article-title":"Efficacy and safety of out-of-hospital self-administered single-dose oral drug treatment in the management of infrequent, well-tolerated paroxysmal supraventricular tachycardia.","volume":"37","author":"Alboni","year":"2001","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"jrv240001r28","first-page":"25","article-title":"Electrophysiological effects, efficacy and safety of intravenous propafenone in termination of atrioventricular nodal reentrant tachycardia and atrioventricular reentrant tachycardia: a prospective non-randomized interventional study.","volume":"49","author":"Pintaric","year":"2010","journal-title":"Acta Clin Croat"},{"issue":"3","key":"jrv240001r29","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.121.010204","article-title":"Open-label, multicenter study of flecainide acetate oral inhalation solution for acute conversion of recent-onset, symptomatic atrial fibrillation to sinus rhythm.","volume":"15","author":"Crijns","year":"2022","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"4","key":"jrv240001r30","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/pace.2006.29.issue-4","article-title":"Efficacy and safety of ibutilide for the conversion of monomorphic atrial tachycardia.","volume":"29","author":"Eidher","year":"2006","journal-title":"Pacing Clin Electrophysiol"},{"issue":"4","key":"jrv240001r31","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S0002-9149(02)03257-5","article-title":"Effectiveness of prehospital synchronous direct-current cardioversion for supraventricular tachyarrhythmias causing unstable hemodynamic states.","volume":"91","author":"Roth","year":"2003","journal-title":"Am J Cardiol"},{"issue":"2","key":"jrv240001r32","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1161\/01.CIR.99.2.262","article-title":"Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricular junction: final results of a prospective, multicenter clinical trial.","volume":"99","author":"Calkins","year":"1999","journal-title":"Circulation"},{"issue":"9","key":"jrv240001r33","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/S0002-9149(02)02285-3","article-title":"Long-term outcomes on quality-of-life and health care costs in patients with supraventricular tachycardia (radiofrequency catheter ablation versus medical therapy).","volume":"89","author":"Goldberg","year":"2002","journal-title":"Am J Cardiol"},{"issue":"11","key":"jrv240001r34","doi-asserted-by":"publisher","first-page":"864","DOI":"10.7326\/0003-4819-133-11-200012050-00010","article-title":"Cost-effectiveness of radiofrequency ablation for supraventricular tachycardia.","volume":"133","author":"Cheng","year":"2000","journal-title":"Ann Intern Med"},{"issue":"1","key":"jrv240001r35","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jacep.2018.09.012","article-title":"Endpoints for successful slow pathway catheter ablation in typical and atypical atrioventricular nodal re-entrant tachycardia: a contemporary, multicenter study.","volume":"5","author":"Katritsis","year":"2019","journal-title":"JACC Clin Electrophysiol"},{"issue":"5","key":"jrv240001r36","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.amjcard.2009.04.040","article-title":"Meta-analysis of ablation of atrial flutter and supraventricular tachycardia.","volume":"104","author":"Spector","year":"2009","journal-title":"Am J Cardiol"},{"issue":"4","key":"jrv240001r37","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1093\/europace\/euw064","article-title":"Catheter ablation vs. antiarrhythmic drug therapy in patients with symptomatic atrioventricular nodal re-entrant tachycardia: a randomized, controlled trial.","volume":"19","author":"Katritsis","year":"2017","journal-title":"Europace"},{"issue":"7","key":"jrv240001r38","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.hrthm.2011.02.008","article-title":"Ablation of atrioventricular nodal reentrant tachycardia in the elderly: results from the German Ablation Registry.","volume":"8","author":"Hoffmann","year":"2011","journal-title":"Heart Rhythm"},{"issue":"8","key":"jrv240001r39","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1093\/europace\/eux269","article-title":"Safety and efficacy of cryoablation vs radiofrequency ablation of septal accessory pathways: systematic review of the literature and meta-analyses.","volume":"20","author":"Bravo","year":"2018","journal-title":"Europace"},{"issue":"19","key":"jrv240001r40","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1056\/NEJMoa035345","article-title":"A randomized study of prophylactic catheter ablation in asymptomatic patients with the Wolff-Parkinson-White syndrome.","volume":"349","author":"Pappone","year":"2003","journal-title":"N Engl J Med"},{"issue":"7","key":"jrv240001r41","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/S0002-9149(00)01531-9","article-title":"Outcomes after radiofrequency catheter ablation of atrial tachycardia.","volume":"87","author":"Anguera","year":"2001","journal-title":"Am J Cardiol"},{"issue":"16","key":"jrv240001r42","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1161\/01.CIR.0000095269.36984.75","article-title":"Electrophysiological and electrocardiographic characteristics of focal atrial tachycardia originating from the pulmonary veins: acute and long-term outcomes of radiofrequency ablation.","volume":"108","author":"Kistler","year":"2003","journal-title":"Circulation"},{"issue":"19","key":"jrv240001r43","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1016\/j.jacc.2009.02.014","article-title":"Tachycardia-mediated cardiomyopathy secondary to focal atrial tachycardia: long-term outcome after catheter ablation.","volume":"53","author":"Medi","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"jrv240001r44","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1067\/mhj.2001.115439","article-title":"Efficacy and safety of dofetilide in the prevention of symptomatic episodes of paroxysmal supraventricular tachycardia: a 6-month double-blind comparison with propafenone and placebo.","volume":"142","author":"Tendera","year":"2001","journal-title":"Am Heart J"},{"issue":"5","key":"jrv240001r45","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S0002-9149(98)00416-0","article-title":"Radiofrequency catheter ablation versus medical therapy for initial treatment of supraventricular tachycardia and its impact on quality of life and healthcare costs.","volume":"82","author":"Bathina","year":"1998","journal-title":"Am J Cardiol"},{"key":"jrv240001r46","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ijcard.2015.07.048","article-title":"AV nodal reentrant tachycardia or AV reentrant tachycardia using a concealed bypass tract-related adverse events.","volume":"199","author":"Brembilla-Perrot","year":"2015","journal-title":"Int J Cardiol"},{"issue":"6","key":"jrv240001r47","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1161\/STROKEAHA.113.001118","article-title":"Paroxysmal supraventricular tachycardia and the risk of ischemic stroke.","volume":"44","author":"Kamel","year":"2013","journal-title":"Stroke"},{"issue":"25","key":"jrv240001r48","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1161\/CIRCULATIONAHA.105.594531","article-title":"Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study.","volume":"113","author":"Friedman","year":"2006","journal-title":"Circulation"},{"issue":"9","key":"jrv240001r49","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1093\/europace\/eut082","article-title":"Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statement.","volume":"15","author":"Brugada","year":"2013","journal-title":"Europace"},{"issue":"5","key":"jrv240001r50","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1161\/CIRCEP.112.972620","article-title":"The Study of Antiarrhythmic Medications in Infancy (SAMIS): a multicenter, randomized controlled trial comparing the efficacy and safety of digoxin versus propranolol for prophylaxis of supraventricular tachycardia in infants.","volume":"5","author":"Sanatani","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"9","key":"jrv240001r51","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1097\/PCC.0000000000000229","article-title":"Comparative effectiveness of digoxin and propranolol for supraventricular tachycardia in infants.","volume":"15","author":"Hornik","year":"2014","journal-title":"Pediatr Crit Care Med"},{"issue":"10","key":"jrv240001r52","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1016\/j.amjcard.2017.02.017","article-title":"Propranolol versus digoxin in the neonate for supraventricular tachycardia (from the Pediatric Health Information System).","volume":"119","author":"Bolin","year":"2017","journal-title":"Am J Cardiol"},{"issue":"6","key":"jrv240001r53","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1017\/S1047951114001619","article-title":"Efficacy of digoxin in comparison with propranolol for treatment of infant supraventricular tachycardia: analysis of a large, national database.","volume":"25","author":"Moffett","year":"2015","journal-title":"Cardiol Young"},{"issue":"3","key":"jrv240001r54","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S0735-1097(01)01773-9","article-title":"Flecainide and sotalol: a new combination therapy for refractory supraventricular tachycardia in children &lt;1 year of age.","volume":"39","author":"Price","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"jrv240001r55","doi-asserted-by":"publisher","first-page":"e251","DOI":"10.1016\/j.hrthm.2016.02.009","article-title":"PACES\/HRS expert consensus statement on the use of catheter ablation in children and patients with congenital heart disease.","volume":"13","author":"Philip Saul","year":"2016","journal-title":"Heart Rhythm"},{"issue":"11","key":"jrv240001r56","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/j.jacep.2021.03.012","article-title":"Outcomes from pediatric ablation: a review of 20 years of national data.","volume":"7","author":"Walsh","year":"2021","journal-title":"JACC Clin Electrophysiol"},{"issue":"7","key":"jrv240001r57","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1046\/j.1540-8167.2004.03645.x","article-title":"Prospective assessment after pediatric cardiac ablation: demographics, medical profiles, and initial outcomes.","volume":"15","author":"Van Hare","year":"2004","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"1","key":"jrv240001r58","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jacc.2004.10.049","article-title":"Transcatheter cryoablation of tachyarrhythmias in children: initial experience from an international registry.","volume":"45","author":"Kirsh","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"jrv240001r59","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/pace.2012.35.issue-6","article-title":"Radiofrequency and cryoablation therapies for supraventricular arrhythmias in the young: five-year review of efficacies.","volume":"35","author":"Buddhe","year":"2012","journal-title":"Pacing Clin Electrophysiol"},{"issue":"12","key":"jrv240001r60","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1111\/jce.2013.24.issue-12","article-title":"Cryoablation versus RF ablation for AVNRT: a meta-analysis and systematic review.","volume":"24","author":"Hanninen","year":"2013","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"11","key":"jrv240001r61","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1093\/europace\/eus103","article-title":"Long-term follow-up after cryoablation for adolescent atrioventricular nodal reentrant tachycardia: recurrence is not predictable.","volume":"14","author":"Reents","year":"2012","journal-title":"Europace"},{"issue":"5","key":"jrv240001r62","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1161\/CIRCEP.114.001517","article-title":"Contemporary management of arrhythmias during pregnancy.","volume":"7","author":"Enriquez","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"34","key":"jrv240001r63","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1093\/eurheartj\/ehy340","article-title":"2018 ESC guidelines for the management of cardiovascular diseases during pregnancy.","volume":"39","author":"Regitz-Zagrosek","year":"2018","journal-title":"Eur Heart J"},{"issue":"1","key":"jrv240001r64","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jacep.2021.10.004","article-title":"Arrhythmias in pregnancy.","volume":"8","author":"Tamirisa","year":"2022","journal-title":"JACC Clin Electrophysiol"},{"issue":"6","key":"jrv240001r65","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1161\/CIRCULATIONAHA.116.025064","article-title":"Outcomes associated with paroxysmal supraventricular tachycardia during pregnancy.","volume":"135","author":"Chang","year":"2017","journal-title":"Circulation"},{"issue":"4","key":"jrv240001r66","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.jacc.2018.10.075","article-title":"Use of medication for cardiovascular disease during pregnancy: JACC state-of-the-art review.","volume":"73","author":"Halpern","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"jrv240001r67","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1253\/circj.CJ-15-0617","article-title":"Beta-blockers and fetal growth restriction in pregnant women with cardiovascular disease.","volume":"80","author":"Tanaka","year":"2016","journal-title":"Circ J"},{"issue":"3","key":"jrv240001r68","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/europace\/euab196","article-title":"Zero-fluoroscopy trans-septal puncture and catheter ablation of a left atrial tachycardia in a pregnant woman with a prosthetic mitral valve.","volume":"24","author":"Ollitrault","year":"2022","journal-title":"Europace"},{"issue":"8","key":"jrv240001r69","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1111\/jce.2010.21.issue-8","article-title":"Ablation of severe drug-resistant tachyarrhythmia during pregnancy.","volume":"21","author":"Szumowski","year":"2010","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"3","key":"jrv240001r70","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/jce.2011.22.issue-3","article-title":"Ablation of incessant left atrial tachycardia without fluoroscopy in a pregnant woman.","volume":"22","author":"Ferguson","year":"2011","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"6","key":"jrv240001r71","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1111\/jce.2015.26.issue-6","article-title":"Catheter ablation of arrhythmia during pregnancy.","volume":"26","author":"Driver","year":"2015","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"1","key":"jrv240001r72","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/eurheartj\/ehaa605","article-title":"2020 ESC guidelines on sports cardiology and exercise in patients with cardiovascular disease.","volume":"42","author":"Pelliccia","year":"2021","journal-title":"Eur Heart J"},{"issue":"4","key":"jrv240001r73","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1177\/1941738113509059","article-title":"Evaluation and management of Wolff-Parkinson-White in athletes.","volume":"6","author":"Rao","year":"2014","journal-title":"Sports Health"},{"issue":"9","key":"jrv240001r74","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1161\/CIRCULATIONAHA.113.008396","article-title":"Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010.","volume":"130","author":"Marelli","year":"2014","journal-title":"Circulation"},{"issue":"17","key":"jrv240001r75","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1161\/CIRCULATIONAHA.109.866319","article-title":"Atrial arrhythmias in adults with congenital heart disease.","volume":"120","author":"Bouchardy","year":"2009","journal-title":"Circulation"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2815194\/jama_peng_2024_rv_240001_1708371523.24519.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T16:01:00Z","timestamp":1708444860000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2815194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,20]]},"references-count":75,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,2,20]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2024.0076","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,20]]}}}